business / markets
8 hours ago

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

https://endpts.com/merck-kgaa-to-buy-rare-cancer-biotech-springworks-for-3-9b/https://seekingalpha.com/news/4436116-merck-kgaa-to-buy-springworks-for-39-billionhttps://www.investopedia.com/germany-s-merck-agrees-to-buy-us-biotech-springworks-therapeutics-for-almost-usd4b-11723041
Endpts.com and 2 more
Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B Open in Endpts.com
Vote 2
0

References

Merck KGaA to buy Springworks for $3.9 billion (MKGAF:Pink Current Info)

https://seekingalpha.com/news/4436116-merck-kgaa-to-buy-springworks-for-39-billionSeekingalpha.com
Merck KGaA to buy Springworks for $3.9 billion (MKGAF:Pink Current Info)

Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B

https://www.investopedia.com/germany-s-merck-agrees-to-buy-us-biotech-springworks-therapeutics-for-almost-usd4b-11723041Investopedia.com
Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Related Articles

Log in to continue reading

Unlimited Access
Personalized Feed
Full Experience

By continuing, you agree to the Privacy Policy. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement